Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Not Yet Recruiting

Role of ERBT Plus Intravesical BCG in Intermediate-Risk or High-Risk NMBC

NCT07724886

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Prince of Wales Hospital Hong Kong

North District Hospital Sheung Shui, Hong Kong

View Trial Details

Not Yet Recruiting

A Study of Radical Cystectomy in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) and Muscle Invasive Bladder Cancer (MIBC) in Korea

NCT07735793

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

LCS103 Herbal Formula for Secondary Prevention of Non-Muscle Invasive Urothelial Carcinoma of the Bladder

NCT07728474

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Rambam Health Care Campus, Urology Department Haifa, Israel

View Trial Details

Not Yet Recruiting

AI-Guided TURBT for Bladder Cancer

NCT07727343

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC

NCT07725796

Conditions: Bladder (Urothelial, Transitional Cell) Cancer, Carcinoma, Female Urogenital Diseases, +20 more
Locations: East Valley Urology Center of Arizona Queen Creek, Arizona, United States

Michael G Oefelein Clinical Trials Bakersfield, California, United States

Urology Center of Southern California Murrieta, California, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details

Not Yet Recruiting

A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

NCT07689812

Conditions: Adenocarcinoma, Advanced Solid Tumors, Advanced Solid Tumors Cancer, +54 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder Cancer

NCT07095751

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Prince of Wales Hospital Hong Kong

View Trial Details

Not Yet Recruiting

CAIX PET/CT for Residual or Recurrent Post-ablative ccRCC

NCT07077083

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Not Yet Recruiting

Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer

NCT07716735

Conditions: Adenocarcinoma, Advanced Kidney Carcinoma, Advanced Renal Cell Carcinoma, +28 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Not Yet Recruiting

Ipilimumab N01 Plus Sintilimab and Lenvatinib as First-line Therapy for Locally Advanced or Metastatic TFE3-Rearranged Renal Cell Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Clinical Trial

NCT07715565

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: West China Hospital, Chengdu, Sichuan 610000 Chengdu, China

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions